Heavy Cannabis Use Linked to Increased Risk of Heart Problems in Canadian Study
A new research report has found that individuals diagnosed with “cannabis use disorder” have a roughly 60% higher chance of experiencing certain heart problems than adults of the same age and gender without the same diagnosis. The study, published in Addiction on Wednesday, was conducted using medical data from just under 60,000 adults in Alberta, […]
MAPS Study Shows Benefits of Using MDMA To Treat PTSD
On Sept. 13, information about the results of a new Phase 3 Trial of MDMA-assisted therapy for PTSD treatment was published by the Multidisciplinary Association for Psychedelic Substances (MAPS). The organization announced that the results of its MAPP2 study have been peer reviewed by the experts with the journal Nature Medicine. The study analyzed the […]
Study: Self-Made Human Cannabinoids May Be Key To Treating Stress-Related Disorders
We already know that humans have our own endocannabinoid systems, made to regulate a number of bodily functions with a number of cannabinoid receptors that interact with compounds like THC and CBD in cannabis. Brain activity patterns and neural circuits regulated by these cannabinoids derived in the brain were not well known, but new research […]
Study Links Simultaneous Cannabis, Tobacco Use to Depression, Anxiety
A new study has found that Americans who regularly use cannabis and tobacco have roughly double the risk for developing symptoms of depression and anxiety than non-users. “Smoking weed and tobacco does not help to deal with anxiety and depression, and may exacerbate mental health issues in the long run,” said lead researcher Nhung Nguyen […]
Researchers Lead First Pilot Study on MDMA Treatment For New Mothers
A study on MDMA treatment for new mothers, which launched in the spring, is being led by Dr. Larry Leeman, the medical director of the University of New Mexico’s Milagro Program. Leeman “treats expectant mothers experiencing opioid use disorder,” and “was dismayed to see that many of his patients eventually resumed opioid use due untreated […]
Canadian Study Links Cannabis Legalization to an Increase in Car Accidents
The results of a recent study published in JAMA Network Open claim to have found an association between cannabis legalization and an increase in traffic accidents. The study was conducted by researchers at the University of Ottawa and looked at emergency room visits in Ontario, Canada over a 13-year period (Jan 2010-Dec 2021 which is […]
Study: Psilocybin ‘Shows Promise’ As Treatment For Depression
A study by American Medical Association, published late last month, sought to measure the “efficacy and safety of psilocybin in patients with major depressive disorder” and to “evaluate the magnitude, timing, and durability of antidepressant effects and safety of a single dose of psilocybin in patients with [major depressive disorder].” Researchers conducted a “a randomized, […]
Study Found That 92% of Illegal Cannabis Samples Contained Pesticides
A recent study published in the Journal of Cannabis Research found shocking evidence of the presence of pesticides in illegal versus legal cannabis from Canada. In “High levels of pesticides found in illicit cannabis inflorescence compared to licensed samples in Canadian study using expanded 327 pesticides multiresidue method,” researchers compared 36 cannabis samples gathered from […]
Study: MMJ Offers Neuropathy Patients Significant Pain, Sleep Improvements
A study published in the journal Medical Cannabis and Cannabinoids conducted out of Hamburg, Germany found that cannabis inhalation is associated with sustained improvements in pain and sleep for patients with chronic neuropathy. Neuropathy is a condition caused by damaged peripheral nerves located outside of the brain and spinal cord, which can cause weakness, numbness […]
Study Analyzes Evidence of Benefits from Using MDMA with Psilocybin, LSD
A recent study published in the journal Scientific Reports found evidence that MDMA can be a beneficial treatment for specific mental health-related conditions. The study consisted of eight researchers from the NYU Langone Center for Psychedelic Medicine in New York, as well as the Imperial College London’s Centre for Psychedelic Research, and its aptly titled […]